---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038647"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2026-08-17T12:30:36+00:00"
generated_at: "2026-08-17T12:35:34.309988+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Dermata raises $3.4M in private placement of shares and warrants

## Summary
- Gross proceeds ~$3.4M; net ~$3.2M after expenses; closing expected Aug 18, 2026.
- Issued 2,293,608 shares (or pre-funded warrants) plus series E and F warrants for 2,293,608 shares each at $1.46.
- Insiders (CEO, CFO, management) bought ~4.9M shares/warrants for ~$2.4M at $1.47 per unit.
- Warrants exercisable at $1.46; series E expire 5 years, series F expire 24 months from stockholder approval; potential $6.7M if exercised.
- Proceeds for general corporate purposes, including OTC acne kit launch and R&D.

## SEC filing metadata
- accession: 0001493152-26-038647
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2026-08-17T12:30:36+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/0001493152-26-038647-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038647
- JSON: https://secwatch.observer/filing/0001493152-26-038647.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038647.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.